A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow of patients with multiple myeloma and acute myeloid leukemia.

A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies. A study from researchers at the University of Michigan and the University of California San ...

A bone marrow transplant, or stem cell transplant, places blood stem cells back into the body. The transplant replaces cells that cancer or treatments have destroyed. A person may have a bone marrow transplant during or after cancer treatment. Bone marrow ...

Why do some patients with precursors to bone marrow cancer never develop the disease? Researchers from the Department of Forensic Medicine at Aarhus University have discovered that some cells enter a dormant state and create a defense against cancer—a ...

“USA250: The Story of the World’s Greatest Economy” is a yearlong WSJ series examining America’s first 250 years. Read more about it from Editor in Chief Emma Tucker. In a federal hospital in Seattle in the 1960s, researchers began testing a ...

DNA changes in certain blood cancers may signal progression to acute myeloid leukemia or myelofibrosis years before routine blood tests detect them.

Researchers at Washington University School of Medicine in St. Louis have discovered lymph node-like structures in the skull bone marrow of mice for the first time and demonstrated that they act as rapid first responders against brain cancer before distant lymph nodes get the signal that abnormal cells are present.

Researchers have discovered that some cells enter a dormant state and create a defense against cancer – a breakthrough that could lead to early treatment. Researchers from the Department of Forensic Medicine at Aarhus University have found the answer.